BPMC — Blueprint Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Blueprint Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	484	872	477	945	711
Net Total Accounts Receivable
Net Total Receivables	23.4	25.3	37	36.9	43.2
Total Inventory
Prepaid Expenses
Total Current Assets	517	928	554	1,047	808
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	111	102	121	115	116
Long Term Investments
Other Long Term Assets
Total Assets	708	1,718	1,252	1,350	1,049
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106	131	150	183	215
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	243	248	281	835	919
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	464	1,470	971	515	131
Total Liabilities & Shareholders' Equity	708	1,718	1,252	1,350	1,049
Total Common Shares Outstanding